Black Logo - Transparent - 500x - Final



The information, including but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.
In 1923, New Mexico banned the cultivation, importation, and sale of cannabis and the cultivation and sale of cannabis remains a federal crime under the Controlled Substances Act. In 1978, however, New Mexico became the first state to pass legislation allowing the medical use of cannabis in some form. Known as the Controlled Substances Therapeutic Research Act, the bill allowed the use of cannabis through a research program approved by the Food and Drug Administration, using cannabis supplied by the National Institute on Drug Abuse. The bill was spurred by the efforts of cancer patient Lynn Pierson, who found relief from using cannabis and pleaded his case to state lawmakers that he should be allowed to use the drug. His efforts were rewarded in February 1978 when the bill was signed into law, following its passage in both chambers of the legislature by wide margins. However, the program still required federal approval, which would not come until August 1978, shortly after Pierson died due to his illness. The approval was then rescinded a few weeks later but, in November 1978, the final go-ahead was given, and cannabis was delivered to the state two months later. Between 1978 and 1986, approximately 250 cancer patients received either cannabis or THC through the Lynn Pierson Therapeutic Research Program.  In April 2007, Governor Bill Richardson signed into law Senate Bill 523, the Lynn and Erin Compassionate Use Act. This bill allowed the use of cannabis with a physician’s recommendation for treatment of certain medical conditions such as  HIV/AIDScancerglaucomamultiple sclerosis, and epilepsy. In later years the list of qualifying conditions was expanded, and an allowance for cultivation by patients was added as well, making New Mexico the 12th state to legalize medical use and the 4th to do so through an act of state legislature. In August 2014, the Santa Fe City Council enacted a citizen-led petition to decriminalize small amounts of cannabis. The law allowed police to issue a $25 civil citation for possession of up to an ounce, and required that minor cannabis offenses be made the lowest police priority. In November 2014, voters in Bernalillo and Santa Fe counties approved ballot measures expressing support for “county, city, and statewide efforts to decriminalize possession of one ounce or less of marijuana.” Initially the referendums were blocked from the ballot by Secretary of State Dianna Duran who claimed that state law did not allow for non-binding questions. the Supreme Court of New Mexico overruled her in September 2014 and the measures passed with 60% and 73% support respectively.
House Bill 2, the Cannabis Regulation Act, was signed into law by Governor Lujan Grisham on April 12, 2021, legalizing legalized cannabis with the following conditions:
  • Possession of cannabis for adults 21 and over will become legal on June 29, 2021. No possession limit will apply at home while a two ounce limit will apply outside the home.
  • Personal cultivation of six mature plants and six immature plants will be allowed per person, with a limit of 12 mature plants per residence.
  • Retail sales of cannabis will begin by April 1, 2022. A 12% excise tax will apply in addition to regular sales taxes. The excise tax will increase 1% each year beginning in 2025, until reaching 18% in 2030.
  • There will be no limit on the number of retail licenses issued by the state. Local governments will be allowed to limit the number of dispensaries or restrict where they are located, but will not be allowed to ban them entirely.
  • Public consumption will remain illegal, but businesses will be allowed to offer on-site consumption if certain requirements are met. On-site consumption has not been approved for the city or county of Santa Fe.
  • Any arrests or convictions for acts made legal by the bill will automatically be expunged.

The first licensed sales of recreational cannabis in New Mexico began on April 1, 2022. Endo reserves at least 20% of its product for medical patients and the state of New Mexico has waived the collection of sales tax for customers with a valid medical marijuana card  The Federal Food, Drug and Cosmetic Act, nevertheless, requires that cannabis related websites remind medical and recreational customers that any statements made regarding cannabis products on this website and by Endo employees have not been evaluated by the Food and Drug Administration. Pharmaceuticals have obtained Orphan Drug and Fast Track designations from the FDA for research as to a limited number of potential medical uses but phase 3 trials for efficacy and monitoring of adverse reactions have not been completed for any THC prescription. The efficacy of cannabis products has not been confirmed by FDA-approved research. Cannabis products are not intended to diagnose, treat, cure or prevent any disease. Information presented in this website or by Endo employees is not meant as a substitute for or an alternative to information from a licensed healthcare practitioner. Please consult your primary care physician or healthcare professional about potential interactions with other prescriptions or other possible complications before using any product.

The information contained in this website is for general information purposes only. The information is provided by Endo and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.

In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.

Through this website you are able to link to other websites which are not under the control of Endo. We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.

Every effort is made to keep the website up and running smoothly. However, Endo takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.